A seriously ill person in
need of embryonic stem cells to repair damaged tissue.
Not exact matches
In fact, when the 2007 paper came out, the commentaries in most scientific publications were quick to point out that, despite the success with adult
cells, there was still a
need to continue embryo - destructive research and that it would be critical to the advancement
of science that research on
embryonic stem cells continue.
The increasing use
of in - vitro - fertilisation techniques, and the emergence
of new possibilities involving human cloning, mixing
of human and animal genetic elements, and the use
of embryonic stem cells for research, among other things, brought the
need for further teaching.
We should not only question the construct
of the «ethics
of curing,» as I will show, but we also
need to look critically at reservations toward research on
embryonic stem cells as they are expressed in our society.
I don't think we
need the same level
of regulation as for human
embryonic stem cells, for example, because we are not using any embryos.
We also
need a more detailed comparison between iPS
cells and
embryonic stem cells in terms
of what they do.
Not only do many
of the ethical challenges posed by
embryonic stem cells remain, but the relative ease and low cost
of iPS techniques, combined with the accessibility
of cells, accelerate the
need to address futuristic - sounding possibilities such as creating gametes for reproduction.
«We studied how the Sox2 gene is turned on in mice, and found the region
of the genome that is
needed to turn the gene on in
embryonic stem cells,» said Professor Jennifer Mitchell
of U
of T's Department
of Cell and Systems Biology, lead invesigator
of a study published in the December 15 issue
of Genes & Development.
They
need exactly the right kind
of cell, which is what we are reporting with
embryonic stem cells.
The rise
of these iPS
cells has reduced the
need for
embryonic stem cells — which have long caused ethical concerns for some — and iPS
cells now form the basis for most
of today's
stem cell research.
He's engaging in classic hype that the religious right uses whenever this issue comes up — claiming that we don't really
need embryonic stem cells because adult
stem cells are so wonderful that they can take care
of everything.
For example we are implementing the use
of the CRISPR mouse mutagenesis technology directly in mouse embryos, which will lead to great savings and acceleration
of projects in their early phase by removing the
need to use
embryonic stem cells.
Although we agree that greater investments are
needed in the clinical development
of these therapies, we disagree with the authors» suggestion that, relative to
embryonic stem cells, adult
stem cells provide a superior vehicle for
cell - based therapies because they lack tumorigenic activity, can be prepared by methods approved by the Food and Drug Administration (FDA), and have been free
of ethical controversy.
Researchers identify a network
of a dozen transcription factors
needed to maintain the pluripotent state
of mouse
embryonic stem cells.
Two months ago, several scientists in Wisconsin and Japan announced that they had successfully created a type
of stem cell from ordinary human skin
cells that seems to be able to function exactly like an
embryonic stem cell without the
need to create or destroy human embryos.
Researchers at the University
of Cambridge have managed to reconstruct the early stage
of mammalian development using
embryonic stem cells, showing that a critical mass
of cells — not too few, but not too many — is
needed for the
cells to being self - organising into the correct structure for an embryo to form.
This two - volume reference integrates this exciting area
of biology, combining the prerequisites for a general understanding
of adult and
embryonic stem cells, the tools, methods, and experimental protocols
needed to study and characterize
stem cells and progenitor populations, as well as a presentation by the world's experts
of what is currently known about each specific organ system.
Lane believes that research in
embryonic stem cells will likely be short - lived, as scientists learn what they
need to know about the function
of cells.
But, by then, human
embryonic stem cells had lost some
of their controversial edge, because scientists really had developed an alternative source
of cells that reduced the
need for material from human embryos.
Opponents
of embryonic stem cell research also are grabbing onto recent scientific advances that they say obviate the
need for destroying embryos.
Patient - specific
stem cells may offer an alternative to
embryonic stem cells that will skirt the
need for immunosuppressive therapy as well as the social and political ramifications
of embryonic stem cell research, but their utility extends far beyond such groundbreaking advances and will assist future clinical practice and patient care.
Embryonic stem cells can be derived from in vitro fertilized (IVF) embryos that are developed in excess
of those
needed for the procedure used to enable infertile couples to have children.